NORMAL SITUATION

Eurotissue Trading & Investment

Export PDF

Company — Normal situation.

Financial year 2024 · Closed on 31/12/2024

Net result42,2 k €-28,2 %over 1 year
Gross margin69,4 k €-34,1 %over 1 year
Equity435,5 k €+10,7 %over 1 year

Identity

Source · BCE/KBO

Eurotissue Trading & Investment is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0466.714.708
Legal form
Private limited company
Contributed capital
12 400,00 €
Latest accounts
31/12/2024
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 28 filings

Trend over 20 financial years

20242023202320222021
Income statement
Gross margin69,4 k €105,4 k €95,4 k €227,9 k €137 k €
EBITDA69 k €103,9 k €95,3 k €226,2 k €135,7 k €
Operating result69 k €96,6 k €124,2 k €220,6 k €133,5 k €
Net result42,2 k €58,7 k €84,1 k €149,7 k €84,7 k €
Balance sheet
Equity435,5 k €393,3 k €584,6 k €500,5 k €350,9 k €
Total assets436,8 k €434,8 k €714,2 k €634,7 k €454,9 k €
Cash396,5 k €316,5 k €531,1 k €367,8 k €256,9 k €
Debts1,3 k €41,5 k €129,6 k €109,2 k €79 k €
Other
Workforce–––––

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 4 ended

Active mandates

Peter Dalstra

Director

Active

Ended mandates

Peter Dalstra

Manager

Ended
Petrus Dalstra

Mandate

Ended
Petrus Dalstra

Director

Ended
Petrus Dalstra

Manager

Ended

Full financial information

Source · NBB
202420232023202220212021
Type of accountMicro modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202408/06/202301/01/202301/01/202201/04/202101/04/2020
Closing of the financial year31/12/202431/12/202307/06/202331/12/202231/12/202131/03/2021
Length of the financial year12 months7 months6 months12 months9 months12 months
Filing date22/05/202515/07/202515/07/202511/07/202326/07/202229/10/2021
General meeting19/02/202521/05/202407/06/202319/05/202314/06/202214/09/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 28 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202419/02/202522/05/2025DutchPDF
Abridged modelCorrection31/12/202321/05/202415/07/2025DutchPDF
Abridged model31/12/202321/05/202408/07/2024DutchPDF
Abridged modelCorrection07/06/202307/06/202315/07/2025DutchPDF
Abridged model07/06/202307/06/202329/01/2024DutchPDF
Abridged model31/12/202219/05/202311/07/2023DutchPDF
Abridged model31/12/202114/06/202226/07/2022DutchPDF
Abridged model31/03/202114/09/202129/10/2021DutchPDF
Micro model31/03/202008/09/202030/10/2020DutchPDF
Micro model31/03/201910/09/201914/10/2019DutchPDF
Micro model31/03/201811/09/201811/10/2018DutchPDF
Micro model31/03/201712/09/201702/10/2017DutchPDF
Abridged model31/03/201613/09/201628/10/2016DutchPDF
Abridged model31/03/201508/09/201525/09/2015DutchPDF
Abridged model31/03/201409/09/201431/10/2014DutchPDF
Abridged model31/03/201310/09/201329/10/2013DutchPDF
Abridged model31/03/201211/09/201231/10/2012DutchPDF
Abridged model31/03/201113/09/201131/10/2011DutchPDF
Abridged model31/03/201014/06/201031/10/2010DutchPDF
Abridged model31/03/200908/09/200918/11/2009DutchPDF
Abridged model31/03/200809/09/200818/11/2008DutchPDF
Abridged model31/03/200711/09/200730/10/2007DutchPDF
Abridged model31/03/200612/09/200631/10/2006DutchPDF
Abridged model31/03/200513/09/200531/10/2005DutchPDF

View all 28 filings

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 4 ended

Active mandates

Peter Dalstra

Director

Active

Ended mandates

Peter Dalstra

Manager

Ended
Petrus Dalstra

Mandate

Ended
Petrus Dalstra

Director

Ended
Petrus Dalstra

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution17/04/2025
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
    PDF
  • Dissolution28/06/2023
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
    PDF
  • Mandates17/01/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 202442,2 k €↓
  2. 2024
    Name changeEurotissue Trading & Investment in vereffening
  3. 2023
    Annual accounts 202358,7 k €↓
  4. 2023
    Annual accounts 202384,1 k €↓
  5. 2022
    Annual accounts 2022149,7 k €↑
  6. 2021
    Annual accounts 202184,7 k €↑
  7. 2021
    Annual accounts 202182,6 k €↑
  8. 2021
    Name changeEurotissue Trading & Investment
  9. 2020
    Annual accounts 202040,9 k €↑
  10. 2019
    Annual accounts 201918,8 k €↑
  11. 2018
    Annual accounts 20189,6 k €↓
  12. 2017
    Annual accounts 2017122,4 k €↑
  13. 2016
    Annual accounts 201645 k €↑
  14. 2015
    Annual accounts 201537,2 k €↑
  15. 2014
    Annual accounts 20149,6 k €↓
  16. 2013
    Annual accounts 201334,2 k €↑
  17. 2012
    Annual accounts 201229,5 k €↑
  18. 2011
    Annual accounts 201126,5 k €↑
  19. 2010
    Annual accounts 201025,9 k €↓
  20. 2009
    Annual accounts 200944,7 k €↑
  21. 2008
    Annual accounts 200840 k €↑
  22. 2007
    Annual accounts 200720,5 k €